ENTITY

Hangzhou Jiuyuan Genetic Biopharmaceutical (2566 HK)

10
Analysis
Health Care • China
Hangzhou Jiuyuan Genetic Biopharmaceutical is a biopharmaceutical company specializing in the research, development, manufacturing, and commercialization of biopharmaceutical products and medical devices. The company focuses on therapeutic areas including orthopedics, metabolic diseases, oncology, and hematology, with key products like Guyoudao for bone repair and Jilifen for neutropenia. It was founded in December 1993 and is headquartered in Hangzhou, China.
more
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
x